Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

CONFIRMATORY ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND 2 (HIV 1/2) - ANVISA Registration 80020690327

Access comprehensive regulatory information for CONFIRMATORY ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND 2 (HIV 1/2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80020690327 and manufactured by manufacturer not specified. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until Aug 25, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 2 companies making the same product including VIVACHEK BIOTECH (HANGZHOU) CO., LTD., BIO-RAD, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
2 Competitors
4 Recent Registrations
80020690327
2 Related Devices
Registration Details
ANVISA Registration Number: 80020690327
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Registration Details

80020690327

25351435855201301

03188198000177

Company Information

Dates and Status

Aug 25, 2014

25/08/2034

09/18/2025 19:00:01

Registration Details

80020690327

25351435855201301

03188198000177

Company Information

BIO-RAD
France
PT: FRANÇA

Dates and Status

Aug 25, 2014

25/08/2034

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "CONFIRMATORY ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND 2 (HIV 1/2)"